Montelukast Sodium
Product Images NDC 43353-879

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 43353-879). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 10mg (43353 879)

Montelukast NA is a medication that comes in a bottle with 9000 tablets, each containing 10mg of Montelukast NA. It is manufactured by Kremers Urban Pharmaceuticals Inc. in Princeton, NJ and repackaged by Aphena Phiamna 858 in Cookeville, TN. The tablets should be stored between 20-25 degrees Celsius and kept out of the reach of children. This medication is prescription-only.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Figure 1 (Montelukast 01)

The text represents a graph showing "Change in Height" over "Weeks on Treatment" for three different types of treatments, including "Montelukast Sodium 5 mg," "Beclomethasone 336 mcg," and "Placebo." The graph shows the change in height in centimeters for each treatment at various points in time, ranging from -19 to 56 weeks.*

FDA Label Image

Chemical Structure (Montelukast 02)

FDA Label Image

Figure 2 (Montelukast 03)

The text appears to be a table showing the mean percent change from a baseline due to treatment with either placebo or Montelukast Sodium at different time intervals (3, 6, 9, 12, and 15 weeks) with a washout period.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.